TNFRSF18
Basic information
Region (hg38): 1:1203508-1206592
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (53 variants)
- not_provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNFRSF18 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004195.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 39 | 46 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 40 | 15 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TNFRSF18 | protein_coding | protein_coding | ENST00000328596 | 4 | 3184 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000145 | 0.128 | 124996 | 0 | 32 | 125028 | 0.000128 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.567 | 175 | 155 | 1.13 | 0.00000940 | 1596 |
Missense in Polyphen | 42 | 42.78 | 0.98178 | 453 | ||
Synonymous | -0.866 | 77 | 67.9 | 1.13 | 0.00000461 | 535 |
Loss of Function | -0.598 | 8 | 6.37 | 1.26 | 2.72e-7 | 70 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000597 | 0.000588 |
Ashkenazi Jewish | 0.000104 | 0.000100 |
East Asian | 0.0000548 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000984 | 0.0000976 |
Middle Eastern | 0.0000548 | 0.0000544 |
South Asian | 0.000294 | 0.000294 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for TNFSF18. Seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death. Mediated NF-kappa-B activation via the TRAF2/NIK pathway.;
- Pathway
- Cytokine-cytokine receptor interaction - Homo sapiens (human);RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs);Gene expression (Transcription);Generic Transcription Pathway;TNFR2 non-canonical NF-kB pathway;Cytokine Signaling in Immune system;RNA Polymerase II Transcription;Immune System;TNFs bind their physiological receptors;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs);Transcriptional regulation by RUNX1;Downstream signaling in naïve CD8+ T cells
(Consensus)
Recessive Scores
- pRec
- 0.164
Haploinsufficiency Scores
- pHI
- 0.0380
- hipred
- N
- hipred_score
- 0.412
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tnfrsf18
- Phenotype
- hematopoietic system phenotype; cellular phenotype; immune system phenotype;
Gene ontology
- Biological process
- positive regulation of leukocyte migration;apoptotic process;signal transduction;tumor necrosis factor-mediated signaling pathway;positive regulation of tyrosine phosphorylation of STAT protein;negative regulation of apoptotic process;regulation of regulatory T cell differentiation;positive regulation of cell adhesion
- Cellular component
- extracellular region;plasma membrane;integral component of plasma membrane
- Molecular function
- tumor necrosis factor-activated receptor activity;protein binding